+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-Invasive Liver Monitor Market by Test Types, Technology, Application, End-User, Patient Type, Targeted Diseases - Global Forecast to 2030- Product Image
Non-Invasive Liver Monitor Market by Test Types, Technology, Application, End-User, Patient Type, Targeted Diseases - Global Forecast to 2030- Product Image
Sale

Non-Invasive Liver Monitor Market by Test Types, Technology, Application, End-User, Patient Type, Targeted Diseases - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055072
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Non-Invasive Liver Monitor Market grew from USD 8.04 billion in 2024 to USD 8.57 billion in 2025. It is expected to continue growing at a CAGR of 6.98%, reaching USD 12.05 billion by 2030.

Redefining Liver Health Assessment in the Modern Era

Non-invasive liver monitoring has emerged as a cornerstone of modern hepatologic care, offering clinicians the ability to detect, stage, and track liver disease without exposing patients to the risks associated with traditional biopsy procedures. Innovations in imaging and biomarker science have coalesced to deliver real-time data on liver stiffness, fibrosis progression, and early pathological changes, driving a paradigm shift from reactive treatment toward proactive disease management. As the burden of chronic liver conditions continues to rise globally, this introduction sets the stage for exploring how cutting-edge diagnostics can alleviate healthcare pressures and improve patient outcomes.

This executive summary distills the critical trends, challenges, and opportunities shaping the non-invasive liver monitoring landscape. By examining technological breakthroughs, policy influences, segmentation nuances, and regional dynamics, readers will gain a holistic perspective on the market’s current trajectory. The insights presented herein are designed for decision-makers seeking to align resource allocation, product development, and strategic partnerships with the dynamic needs of patients and healthcare providers in this rapidly evolving sector.

Emerging Shifts Driving Momentum in Liver Monitoring Technologies

Over the past decade, non-invasive liver monitoring has undergone transformative shifts driven by the convergence of advanced imaging modalities, digital health platforms, and novel biomarker discovery. Artificial intelligence and machine learning algorithms now play a pivotal role in enhancing the accuracy of elastography readings and predicting fibrotic progression based on longitudinal patient data. Simultaneously, the integration of telemedicine capabilities has enabled remote assessment of liver health, expanding access to specialty care in underserved regions and reducing the burden on tertiary centers.

Regulatory bodies have accelerated the clearance of innovative devices and assay panels, reflecting a growing consensus on the clinical value of non-invasive approaches. Parallel advancements in serum biomarker panels and scoring systems have complemented imaging techniques, delivering a multifaceted diagnostic toolkit. These shifts collectively underscore a broader move toward personalized, data-driven management of liver disease, reinforcing the market’s momentum and opening new avenues for product differentiation and strategic collaboration.

Assessing the Impact of 2025 US Tariff Changes on Liver Monitoring

The introduction of new tariffs by the United States in 2025 is poised to reshape the competitive dynamics of the non-invasive liver monitoring market. With levies targeting imported imaging equipment components and reagents used in biomarker assays, many manufacturers will face higher production costs. These added expenses may translate into increased pricing for end-users, challenging diagnostic centers and hospitals striving to maintain cost-effective patient care.

Supply chain resilience will become a focal point as companies seek to mitigate the impact of tariff-driven disruptions. Strategies may include diversifying manufacturing bases, pursuing alternative sourcing agreements, and accelerating domestic production of critical components. At the same time, stakeholders will need to engage proactively with policymakers to advocate for exemptions or adjustments that preserve market accessibility. In this context, organizations that can navigate the tariff landscape while preserving innovation pipelines and maintaining affordability will emerge as leaders in the next phase of market evolution.

Unveiling Critical Segmentation Insights Across Testing Modalities

The market for non-invasive liver monitoring can be dissected through multiple lenses that reveal distinct competitive and growth opportunities. When viewed by test type, blood-based biomarker tests deliver minimally invasive snapshots of liver function, while imaging-based tests provide real-time visualization of tissue elasticity and fibrosis. Examining the landscape through a technology standpoint highlights the complementary roles of Computed Tomography-based techniques and Magnetic Resonance Elastography, which offer high-resolution imaging, alongside ultrasound elastography and near-infrared spectroscopy, each balancing precision with cost-effectiveness. Concurrently, serum biomarker panels and scoring algorithms have matured to enhance early detection and risk stratification.

From an application perspective, market demands are shaped by requirements for disease staging and monitoring, the critical window of early disease diagnosis, and the long-term management of patients post-surgery. End-user dynamics further segment the field among diagnostic centers focused on high-throughput screening, hospitals and clinics prioritizing integrative patient management, and research institutions driving next-generation innovation. Patient demographics create additional nuances, with adult populations representing the largest user base, geriatric cohorts demanding specialized considerations, and pediatric patients requiring tailored approaches. Finally, targeted disease categories-ranging from cirrhosis and fatty liver disease to hepatitis B, hepatitis C, and liver fibrosis-drive specific technology adoption curves and investment priorities.

Exploring Regional Dynamics Shaping the Global Market

Regional dynamics in non-invasive liver monitoring underscore divergent growth trajectories and regulatory environments. In the Americas, established reimbursement frameworks and high healthcare spending fuel adoption of advanced elastography platforms and biomarker panels, while market saturation in major urban centers prompts companies to explore rural outreach and telehealth applications. Across Europe, the Middle East, and Africa, harmonization of regulatory standards and multinational health initiatives have accelerated clinical acceptance of non-invasive diagnostics, though economic disparities between regions necessitate flexible business models and tiered product offerings.

Asia-Pacific stands out for its robust emergence as a high-growth arena, driven by rising liver disease prevalence, expanding healthcare infrastructure, and government-backed screening programs. Local manufacturing capabilities are also coming online, enabling competitive pricing and rapid deployment of imaging devices. Taken together, these regional patterns highlight the importance of tailored market entry strategies, dynamic pricing structures, and partnerships with local stakeholders to capture value in diverse healthcare environments.

Leading Innovators Reshaping Non-Invasive Liver Monitoring

The competitive landscape of non-invasive liver monitoring is characterized by a mix of established medical device giants and agile innovators. Leading equipment manufacturers have invested heavily in next-generation imaging platforms, integrating artificial intelligence to enhance diagnostic precision and workflow efficiency. Concurrently, specialized firms have distinguished themselves through proprietary biomarker panels and digital scoring systems that complement imaging data, forging partnerships with academic institutions to validate clinical performance.

Strategic mergers and acquisitions have reshaped market positioning, enabling larger players to augment their portfolios with niche capabilities in elastography or biomarker assay development. R&D pipelines emphasize miniaturization, portability, and seamless electronic health record integration, reflecting a broader trend toward point-of-care testing. Companies that can balance scale with innovation agility are well placed to define the future of non-invasive liver monitoring and secure sustainable growth amid intensifying competition.

Strategic Actions to Strengthen Market Leadership

Industry leaders must embrace a multifaceted strategy to capitalize on emerging opportunities in non-invasive liver monitoring. Investment in advanced imaging modalities such as elastography and magnetic resonance elastography should be matched by parallel development of robust serum biomarker panels that offer cost-effective early disease detection. Strengthening collaborations with academic centers and clinical networks will accelerate validation studies and foster evidence generation that informs payer coverage decisions.

To navigate the evolving tariff landscape, companies should diversify supply chains by establishing regional manufacturing hubs and securing long-term sourcing agreements. Engaging proactively with regulatory agencies can help shape favorable policy outcomes and expedite market access for breakthrough technologies. Finally, embedding digital health solutions-from AI-driven analytics to telehealth platforms-will enhance patient engagement, enable remote monitoring, and support value-based care models that resonate with payers and providers alike.

Rigorous Methodology Underpinning Comprehensive Analysis

This analysis is underpinned by a rigorous research methodology that combines exhaustive secondary research with targeted primary interviews and quantitative data triangulation. Secondary sources include peer-reviewed journals, government health reports, regulatory filings, and industry white papers. Primary interviews were conducted with key opinion leaders, clinical end-users, and senior executives from device manufacturers to validate market intelligence and capture nuanced perspectives on adoption drivers.

Quantitative market segmentation was achieved by synthesizing shipment data from regulatory databases and cross-referencing with installation records from major healthcare systems. Regional market dynamics were assessed using public health statistics and trade data, while tariff impacts were modeled based on tariff schedules and cost pass-through scenarios. Finally, all findings were peer-reviewed by an internal panel of industry analysts to ensure accuracy, relevance, and methodological transparency.

Synthesis of Key Insights and Future Outlook

Non-invasive liver monitoring has transcended its early experimental roots to become an indispensable tool in hepatology, driven by relentless technological innovation and evolving clinical practices. Key insights reveal that integration of imaging and biomarker approaches offers the most comprehensive diagnostic coverage, while regional and regulatory nuances demand tailored go-to-market strategies. The looming tariff adjustments in the United States underscore the need for resilient supply chains and proactive policy engagement.

As market players refine their segmentation strategies and expand global footprints, success will depend on the ability to deliver clinically validated, cost-efficient solutions that align with the shifting priorities of providers, payers, and patients. Continued collaboration across industry, academia, and regulatory bodies will be essential for accelerating adoption and unlocking the full potential of non-invasive liver diagnostics in improving patient care and reducing the burden of liver disease worldwide.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Test Types
    • Blood-Based Biomarker Tests
    • Imaging-Based Tests
  • Technology
    • Computed Tomography (CT)-Based Techniques
    • Magnetic Resonance Elastography (MRE)
    • Near-Infrared Spectroscopy (NIRS)
    • Serum Biomarker Panels & Scoring
    • Ultrasound Elastography
  • Application
    • Disease Staging & Monitoring
    • Early Disease Diagnosis
    • Post-Surgery Monitoring
  • End-User
    • Diagnostic Centers
    • Hospitals & Clinics
    • Research Institutions
  • Patient Type
    • Adult
    • Geriatric
    • Pediatric
  • Targeted Diseases
    • Cirrhosis
    • Fatty Liver Disease
    • Hepatitis
      • Hepatitis B
      • Hepatitis C
    • Liver Fibrosis
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Alpinion Medical Systems USA Inc.
  • Bruker Corporation GmbH
  • Canon Medical Systems Corporation
  • Chison Medical Imaging Co., Ltd.
  • Clarius Mobile Health, Inc.
  • Echosens S.A.
  • Esaote S.p.A.
  • F. Hoffmann-La Roche AG
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • iLiv Diagnostics Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • Mindray Medical International Limited
  • Perspectum Diagnostics Ltd.
  • Quibim
  • Randox Laboratories Ltd.
  • Resonance Health Limited
  • Resoundant, Inc.
  • Samsung Medison Co., Ltd.
  • Siemens Healthcare Private Limited
  • Supersonic Imagine S.A.
  • Wuxi HISKY Medical Technologies Co., Ltd.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Non-Invasive Liver Monitor Market, by Test Types
8.1. Introduction
8.2. Blood-Based Biomarker Tests
8.3. Imaging-Based Tests
9. Non-Invasive Liver Monitor Market, by Technology
9.1. Introduction
9.2. Computed Tomography (CT)-Based Techniques
9.3. Magnetic Resonance Elastography (MRE)
9.4. Near-Infrared Spectroscopy (NIRS)
9.5. Serum Biomarker Panels & Scoring
9.6. Ultrasound Elastography
10. Non-Invasive Liver Monitor Market, by Application
10.1. Introduction
10.2. Disease Staging & Monitoring
10.3. Early Disease Diagnosis
10.4. Post-Surgery Monitoring
11. Non-Invasive Liver Monitor Market, by End-User
11.1. Introduction
11.2. Diagnostic Centers
11.3. Hospitals & Clinics
11.4. Research Institutions
12. Non-Invasive Liver Monitor Market, by Patient Type
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Non-Invasive Liver Monitor Market, by Targeted Diseases
13.1. Introduction
13.2. Cirrhosis
13.3. Fatty Liver Disease
13.4. Hepatitis
13.4.1. Hepatitis B
13.4.2. Hepatitis C
13.5. Liver Fibrosis
14. Americas Non-Invasive Liver Monitor Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Non-Invasive Liver Monitor Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Non-Invasive Liver Monitor Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Alpinion Medical Systems USA Inc.
17.3.3. Bruker Corporation GmbH
17.3.4. Canon Medical Systems Corporation
17.3.5. Chison Medical Imaging Co., Ltd.
17.3.6. Clarius Mobile Health, Inc.
17.3.7. Echosens S.A.
17.3.8. Esaote S.p.A.
17.3.9. F. Hoffmann-La Roche AG
17.3.10. Fujifilm Holdings Corporation
17.3.11. GE HealthCare Technologies Inc.
17.3.12. Hologic, Inc.
17.3.13. iLiv Diagnostics Inc.
17.3.14. Konica Minolta, Inc.
17.3.15. Koninklijke Philips N.V.
17.3.16. Mindray Medical International Limited
17.3.17. Perspectum Diagnostics Ltd.
17.3.18. Quibim
17.3.19. Randox Laboratories Ltd.
17.3.20. Resonance Health Limited
17.3.21. Resoundant, Inc.
17.3.22. Samsung Medison Co., Ltd.
17.3.23. Siemens Healthcare Private Limited
17.3.24. Supersonic Imagine S.A.
17.3.25. Wuxi HISKY Medical Technologies Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. NON-INVASIVE LIVER MONITOR MARKET MULTI-CURRENCY
FIGURE 2. NON-INVASIVE LIVER MONITOR MARKET MULTI-LANGUAGE
FIGURE 3. NON-INVASIVE LIVER MONITOR MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2024 VS 2030 (%)
FIGURE 18. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. NON-INVASIVE LIVER MONITOR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. NON-INVASIVE LIVER MONITOR MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NON-INVASIVE LIVER MONITOR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY BLOOD-BASED BIOMARKER TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY IMAGING-BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT)-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY MAGNETIC RESONANCE ELASTOGRAPHY (MRE), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY NEAR-INFRARED SPECTROSCOPY (NIRS), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY SERUM BIOMARKER PANELS & SCORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY ULTRASOUND ELASTOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY DISEASE STAGING & MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY EARLY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY POST-SURGERY MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY CIRRHOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY FATTY LIVER DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY LIVER FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 52. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 57. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 58. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 59. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 64. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 94. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 95. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 100. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 101. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 102. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 107. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 115. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 116. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 121. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 122. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 123. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 128. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 150. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 151. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 156. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 164. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 165. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 169. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 170. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 171. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 172. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 177. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 192. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 193. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 197. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 198. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 199. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 200. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 204. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 205. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 213. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 214. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 218. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 219. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 220. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 221. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 225. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 226. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 242. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 243. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 247. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 248. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 249. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 250. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 254. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 255. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 256. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 257. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 261. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 262. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 284. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 285. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 289. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 290. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN NO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Non-Invasive Liver Monitor market report include:
  • Abbott Laboratories
  • Alpinion Medical Systems USA Inc.
  • Bruker Corporation GmbH
  • Canon Medical Systems Corporation
  • Chison Medical Imaging Co., Ltd.
  • Clarius Mobile Health, Inc.
  • Echosens S.A.
  • Esaote S.p.A.
  • F. Hoffmann-La Roche AG
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • iLiv Diagnostics Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • Mindray Medical International Limited
  • Perspectum Diagnostics Ltd.
  • Quibim
  • Randox Laboratories Ltd.
  • Resonance Health Limited
  • Resoundant, Inc.
  • Samsung Medison Co., Ltd.
  • Siemens Healthcare Private Limited
  • Supersonic Imagine S.A.
  • Wuxi HISKY Medical Technologies Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.57 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.05 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Bilirubin Meters Market Report 2025 - Product Image

Bilirubin Meters Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Biopsy Devices Market by Product Type, Application, End User - Global Forecast to 2030 - Product Image

Biopsy Devices Market by Product Type, Application, End User - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Brain Trauma Monitoring Equipment Market by Product Type, Technology, End User, Application, Components, Distribution Channel - Global Forecast to 2030 - Product Image

Brain Trauma Monitoring Equipment Market by Product Type, Technology, End User, Application, Components, Distribution Channel - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Bilirubin Meters - Global Strategic Business Report - Product Image

Bilirubin Meters - Global Strategic Business Report

  • Report
  • 454 Pages
  • Global
From
Medical Robotic Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Medical Robotic Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.